OOIR: Observatory of International Research

Papers

(The TQCC of Cardiology Clinics is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Hypertensive Disorders of Pregnancy	67
Thoracic Aortic Aneurysm	44
The Impact of Uric Acid and Hyperuricemia on Cardiovascular and Renal Systems	28
State of the Art	28
Hypertension and Heart Failure	28
The Importance of Cardiovascular Risk Assessment and Pregnancy Heart Team in the Management of Cardiovascular Disease in Pregnancy	21
Dyslipidemia in Patients with Kidney Disease	21
The Pathobiology of Pulmonary Arterial Hypertension	20
Stent Thrombosis After Percutaneous Coronary Intervention	19
Valvular Heart Disease in Pregnancy	18
Varicose Veins and Chronic Venous Disease	16
Echocardiographic Strain Imaging in Coronary Artery Disease	14
Cardiovascular Health Care Implications of the COVID-19 pandemic	14
MicroRNAs and Long Noncoding RNAs in Coronary Artery Disease	13
Uremic Toxins and Cardiovascular System	13
Pulmonary Arterial Hypertension in Pregnancy	13
New Antidiabetes Medications and Their Cardiovascular and Renal Benefits	13
Anomalous Coronary Arteries	12
Delivering Coordinated Cardio-Obstetric Care from Preconception through Postpartum	12
Risk Stratification and Management of Extracranial Carotid Artery Disease	11
Chronic Obstructive Pulmonary Disease and Heart Failure	11
The Impact of Obesity in Heart Failure	10
Myocarditis Following COVID-19 Vaccination	10
The Cardiovascular Manifestations of COVID-19	10
Cardiovascular Contribution to Maternal Mortality	9

Impact of COVID-19 on Acute Myocardial Infarction Care	9
Cardiorenal Syndrome	9
Cardiac Cachexia Revisited	9
Advances in Diagnosis and Treatment of Cardiac and Renal Amyloidosis	9
A Comparison of Hemodialysis and Peritoneal Dialysis in Patients with Cardiovascular Disease	8
Advances in Mitral Valve Repair for Degenerative Mitral Regurgitation	8
Mitral Annular Disjunction—A New Disease Spectrum	8
Pregnancy in Women with Adult Congenital Heart Disease	8
Hypertrophic Cardiomyopathy in Pregnancy	8
Acute Aortic Syndromes	8
Pulmonary Hypertension Associated with Connective Tissue Disease	8
Pulmonary Hypertension in Adults with Congenital Heart Disease	7
Epidemiology, Diagnosis, Pathophysiology, and Initial Approach to Heart Failure with Preserved Ejection Fraction	7
Pulmonary Hypertension in Chronic Kidney Disease	7
Looking into the Mechanistic Link Between Mitral Regurgitation and Atrial Fibrillation	7
Device Therapy for Heart Failure with Preserved Ejection Fraction	7
Noninvasive Imaging Risk Stratification with Computed Tomography Angiography for Coronary Artery Disease	7
Arrhythmias and Pregnancy	7
A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19	7
Use and Prognostic Implications of Cardiac Troponin in COVID-19	7
Bioresorbable Coronary Scaffold Technologies	6
The Gut Axis Involvement in Heart Failure	6
Ischemic Heart Disease in Pregnancy	6
The Tactical Athlete	6
Left Heart Disease-Related Pulmonary Hypertension	6
The International Criteria for Electrocardiogram Interpretation in Athletes	6
Optimal Timing of Surgery for Patients with Active Infective Endocarditis	6
Refractory Angina—Unsolved Problem	6
Complete Revascularization in Acute and Chronic Coronary Syndrome	6
Impact of Coronavirus Disease 2019 Pandemic on Cardiac Arrest and Emergency Care	6
Coronary Physiology Assessment for the Diagnosis and Treatment of Coronary Artery Disease	6
Positron Emission Tomography Imaging in Vasculitis	6
Psychological Disorders in Heart Failure	5
New Advances in the Treatment of Severe Coronary Artery Calcifications	5
Exercise After Acute Myocarditis	5
Cardiovascular Medications in Pregnancy	5
Medical Management of Peripheral Artery Disease	5
Raynaud Phenomenon and Other Vasospastic Disorders	5
Pharmacologic Therapy for Heart Failure with Preserved Ejection Fraction	5
Role of Mitral Valve Repair for Mitral Infective Endocarditis	5
Nonpharmacological Strategies in Heart Failure with Preserved Ejection Fraction	5
Atherosclerotic Vascular Disease Associated with Chronic Kidney Disease	5
Pulmonary Arterial Hypertension in Patients Infected with the Human Immunodeficiency Virus	5
Artificial Intelligence in Nuclear Cardiology	4
Peripartum Cardiomyopathy	4
Key Phenotypes of Heart Failure with Preserved Ejection Fraction	4
The Cardiorenal Syndrome in Heart Failure	4
Introduction to Nephrocardiology	4
Update on Medical Management of Pulmonary Arterial Hypertension	4
Current and Future Application of Transcatheter Mitral Valve Replacement	4

Management of Pulmonary Hypertension in the Pediatric Patient	4
Abdominal Aortic and Visceral Artery Aneurysms	4
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination	4
Hemodynamic Assessment in Heart Failure with Preserved Ejection Fraction	4
Advances in the Diagnosis and Treatment of Coronary Artery Disease	4
Sinus Node Dysfunction	4
Transthyretin Cardiac Amyloidosis	4